News

The novel formulation of citalopram hydrobromide (HBr) may offer physicians a new dosing option with potential benefits and prescribing flexibility that may be advantageous when addressing the needs

Sirna completed its preclinical evaluation of the efficacy of Sirna-AV34 and has begun manufacturing for its phase I clinical studies. Sirna will conduct toxicology studies in the first

Nexavar, which has been shown to double progression-free survival in patients with advanced RCC, is the first FDA-approved treatment for this type of cancer in more than a

The company’s initial clinical development of TNX-650 will focus on the agent’s use as monotherapy in patients who have relapsed or are refractory to standard chemotherapy with or

The collaboration will specifically use TransTech’s proprietary TTP translational technology. TransTech is set to receive up to $54 million in a combination of an upfront payment, research support

Auxilium will now receive exclusive global rights to develop and commercialize AA4500 (adhesive capsulitis) for the new indication of frozen shoulder syndrome. Auxilium already has an exclusive global

The rheumatoid arthritis trial will evaluate R788 in combination with methotrexate a commonly used treatment for the disease. R788 is a novel, oral syk kinase inhibitor that blocks

Lexicon received the first of these payments for the completion of the analysis of the physiological and behavioral functions of the final set of targets selected from Genentech’s

The collaborators are to design a study to assess the use of Gardasil in India. Upon completion of the study, the partners will work together to assess the